Repligen reported $0 in Loan Capital for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Agilent A:US USD 2.73B 0
Bio Techne TECH:US USD 200M 64.66M
Biomarin Pharmaceutical BMRN:US USD 1.08B 1.17M
Bruker BRKR:US USD 1.2B 63.7M
Catalent CTLT:US USD 4.22B 123M
Charles River Laboratories CRL:US USD 2.71B 229.52M
Danaher DHR:US USD 19.09B 544M
Dentsply International XRAY:US USD 1.83B 89M
Exact Sciences EXAS:US USD 2.24B 881K
Fluidigm FLDM:US USD 62.81M 1.08M
General Electric GE:US USD 28.59B 2.47B
Henry Schein HSIC:US USD 1.04B 106M
Illumina ILMN:US USD 1.49B 992M
IQVIA Holdings Inc IQV:US USD 12.6B 352M
Mettler Toledo International MTD:US USD 1.91B 83.23M
Nanostring Technologies NSTG:US USD 226.62M 372K
Orasure Technologies OSUR:US USD 503K 432K
Patterson Companies PDCO:US USD 451.91M 33.61M
Perkinelmer PKI:US USD 3.92B 25.08M
Thermo Fisher Scientific TMO:US USD 28.91B 759M
Waters WAT:US USD 1.57B 80.25M
West Pharmaceutical Services WST:US USD 208.9M 1.7M